Taken together, these results implied that GREM1 induced EMT in CRC cells by inhibiting ATF4 expression and promoting ATF6 expression through the regulation of TGFβ/BMP and VEGF/VEGFR2, respectively. The gene discussed is ATF6; the disease is colorectal carcinoma.